Pharmanutra SpA
MIL:PHN

Watchlist Manager
Pharmanutra SpA Logo
Pharmanutra SpA
MIL:PHN
Watchlist
Price: 56.9 EUR 6.55% Market Closed
Market Cap: 546.7m EUR
Have any thoughts about
Pharmanutra SpA?
Write Note

Wall Street
Price Targets

PHN Price Targets Summary
Pharmanutra SpA

Wall Street analysts forecast PHN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHN is 82.96 EUR with a low forecast of 76.76 EUR and a high forecast of 90.3 EUR.

Lowest
Price Target
76.76 EUR
35% Upside
Average
Price Target
82.96 EUR
46% Upside
Highest
Price Target
90.3 EUR
59% Upside
Pharmanutra SpA Competitors:
Price Targets
1707
Grape King Bio Ltd
12% Upside
EL
Estee Lauder Companies Inc
71% Upside
MED
Medifast Inc
9% Downside
NTCO3
Natura & Co Holding SA
36% Upside
300740
SYoung Group Co Ltd
31% Upside
JWEL
Jamieson Wellness Inc
12% Upside
COLPAL
Colgate-Palmolive (India) Ltd
15% Upside
KAMART
Karmarts PCL
39% Upside

Revenue
Forecast

Revenue Estimate
Pharmanutra SpA

For the last 7 years the compound annual growth rate for Pharmanutra SpA's revenue is 17%. The projected CAGR for the next 3 years is 14%.

17%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Pharmanutra SpA

For the last 7 years the compound annual growth rate for Pharmanutra SpA's operating income is 21%. The projected CAGR for the next 3 years is 14%.

21%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Pharmanutra SpA

For the last 7 years the compound annual growth rate for Pharmanutra SpA's net income is 19%. The projected CAGR for the next 3 years is 25%.

19%
Past Growth
25%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHN's stock price target?
Price Target
82.96 EUR

According to Wall Street analysts, the average 1-year price target for PHN is 82.96 EUR with a low forecast of 76.76 EUR and a high forecast of 90.3 EUR.

What is Pharmanutra SpA's Revenue forecast?
Projected CAGR
14%

For the last 7 years the compound annual growth rate for Pharmanutra SpA's revenue is 17%. The projected CAGR for the next 3 years is 14%.

What is Pharmanutra SpA's Operating Income forecast?
Projected CAGR
14%

For the last 7 years the compound annual growth rate for Pharmanutra SpA's operating income is 21%. The projected CAGR for the next 3 years is 14%.

What is Pharmanutra SpA's Net Income forecast?
Projected CAGR
25%

For the last 7 years the compound annual growth rate for Pharmanutra SpA's net income is 19%. The projected CAGR for the next 3 years is 25%.

Back to Top